AKTX
Akari Therapeutics
AKTX
AKTX
11 hedge funds and large institutions have $11.5M invested in Akari Therapeutics in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SCM
1
Sio Capital Management
New York
|
$881K |
2 |
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
|
$1.44M |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3K |
4 |
4
Citigroup
New York
|
$1K |
Top Sellers
1 |
1
HighTower Advisors
Chicago,
Illinois
|
$66K |
2 |
PCM
2
Prelude Capital Management
New York
|
$0 |
3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$2.59K |